Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

Biogen did a deep dive on A 2-73 years ago under the MTA for the remylenation research program. The program apparently ended in failure since nothing further happened.

Biogen has a market cap of almost $38 billion. It is one of the most successful biotech companies ever. There are very smart people running the company with a strong track record of many more successes than failures. Biogen is well aware of Anavex. If Biogen thought Anavex had anything of real value or that Anavex was a competitive threat, they’d have bought the company at a premium long ago in a deal that Anavex’s board and shareholders would not / could not have refused. (Before you say that Missling would have refused, keep in mind that any serious offers to acquire the company would have to have been disclosed. None were.)

Enjoy your very creative fantasy.